Lecanemab in Early Alzheimers DiseaseNEJM 388:9-21,80, van Dyck,A.H.,et al, 2023
Controversy and Progress in Alzheimers Disease - FDA Approval of AducanumabNEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021